JAK2 degradation by strebloside dismantles PD-L1-mediated immune evasion in EBV-associated gastric cancer
- 11 June 2026
- journal article
- Published by Elsevier in Translational Research
- Vol. 295, 13-30
Abstract
No abstract availableKeywords
Funding Information
- Fundamental Research Funds for the Central Universities (2632025XCZX02)
- National University's Basic Research Foundation of China
- National Natural Science Foundation of China (82574277)
This publication has 23 references indexed in Scilit:
- Dynamic single-cell mapping unveils Epstein‒Barr virus-imprinted T-cell exhaustion and on-treatment responseSignal Transduction and Targeted Therapy, 2023
- Estimating the Global Burden of Epstein-Barr Virus–Associated Gastric Cancer: A Systematic Review and Meta-AnalysisClinical Gastroenterology and Hepatology, 2022
- Cardiac glycosides from the roots of Streblus asper Lour. with activity against Epstein-Barr virus lytic replicationBioorganic Chemistry, 2022
- Atomic zinc sites with hierarchical porous carbon for high-throughput chemical screening with high loading capacity and stabilityPharmacological Research, 2022
- DNA damage response- and JAK-dependent regulation of PD-L1 expression in head and neck squamous cell carcinoma (HNSCC) cells exposed to 5-fluorouracil (5-FU)Translational Oncology, 2021
- Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathwayActa Pharmacologica Sinica, 2020
- EBV-associated gastric cancer evades T-cell immunity by PD-1/PD-L1 interactionsGastric Cancer, 2018
- (+)-Strebloside-Induced Cytotoxicity in Ovarian Cancer Cells Is Mediated through Cardiac Glycoside Signaling NetworksJournal of Natural Products, 2017
- Comprehensive molecular characterization of gastric adenocarcinomaNature, 2014
- The blockade of immune checkpoints in cancer immunotherapyNature Reviews Cancer, 2012